Dunn Edmund Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$11,042.26

Insider Activity of Dunn Edmund

According to the SEC Form 4 filings, Dunn Edmund, being in a position of

  1. Principal Accounting Officer at Monte Rosa Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 26878 shares for $483,144,
    over all time since 2024-06-03, has bought 0 shares, and sold 31757 shares for $503,361.

Biography of Dunn Edmund

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$483,1444100

Comparison of Insiders on Amount of Buys and Sells

2026-03-04SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
139
0.0002%
$17.96$2,496-9.03%
2026-03-02SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
536
0.0008%
$17.50$9,380-8.11%
2026-02-27SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
25,164
0.0394%
$18.10$455,506-4.06%
2026-01-05SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
1,039
0.0016%
$15.17$15,762+23.61%
2025-06-03SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
2,062
0.0032%
$4.45$9,174+232.11%
2024-07-05SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
1,610
0.0027%
$3.83$6,166+51.37%
2024-06-03SaleMonte Rosa Therapeutics, Inc.
GLUE
Principal Accounting Officer
1,207
0.002%
$4.04$4,876+38.32%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.